Anneke J. van Vuuren
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Anneke J. van Vuuren has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Iris Lansdorp-Vogelaar
Department of Public Health Erasmus University Medical Center Rotterdam The Netherlands
2 shared publications - Monique E. van Leerdam
Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, The Netherlands
2 shared publications Aafke H.C. van Roon
Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, The Netherlands
1 shared publication- Arthur I. Kooyker
Department of Public Health, Erasmus MC University Medical Center, Rotterdam, Netherlands
1 shared publication - Atija Kapidzic
Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, The Netherlands
1 shared publication Caspar W.N. Looman
Department of Public Health, Erasmus University Medical Center, Rotterdam, the Netherlands
1 shared publication
Latest Publications
- Open Access
- 1 December 2022
- Published by Wiley in International Journal of Cancer
- Vol. 152 (8) , 1536-1546
Factors associated with interval colorectal cancer after negative FIT: Results of two screening rounds in the Dutch FIT‐based CRC screening program
The interval colorectal cancer (CRC) rate after negative fecal immunochemical testing (FIT) is an important quality indicator of CRC screening programs. We analyzed the outcomes of two rounds of the FIT‐based CRC screening program in the Netherlands, using data from individuals who participated in FIT‐screening from 2014 to 2017. Data of individuals with one prior negative FIT (first round) or two prior negative FITs (first and second round) were included. Outcomes included the incidence of interval CRC in FIT‐negative participants (40‐46.9 μg/g) had a higher probability of detecting an interval CRC (OR 16.9; 95%CI: 14.0‐20.4) than had participants with unmeasurable f‐Hb (0‐2.6 μg/g). After two screening rounds, the odds ratio for interval CRC was 12.0 (95%CI: 7.8‐17.6) for participants with f‐Hb just below the cut‐off compared with participants with unmeasurable f‐Hb. After both screening rounds, the Dutch CRC screening program had a low incidence of interval CRC and an associated high FIT‐sensitivity. Our findings suggest there is a potential for further optimizing CRC screening programs with the use of risk‐stratified CRC screening based on prior f‐Hb.
- 1 December 2022
- Published by Wiley in International Journal of Cancer
- Vol. 152 (8) , 1536-1546
Open AccessFactors associated with interval colorectal cancer after negative FIT: Results of two screening rounds in the Dutch FIT‐based CRC screening program
The interval colorectal cancer (CRC) rate after negative fecal immunochemical testing (FIT) is an important quality indicator of CRC screening programs. We analyzed the outcomes of two rounds of the FIT‐based CRC screening program in the Netherlands, using data from individuals who participated in FIT‐screening from 2014 to 2017. Data of individuals with one prior negative FIT (first round) or two prior negative FITs (first and second round) were included. Outcomes included the incidence of interval CRC in FIT‐negative participants (40‐46.9 μg/g) had a higher probability of detecting an interval CRC (OR 16.9; 95%CI: 14.0‐20.4) than had participants with unmeasurable f‐Hb (0‐2.6 μg/g). After two screening rounds, the odds ratio for interval CRC was 12.0 (95%CI: 7.8‐17.6) for participants with f‐Hb just below the cut‐off compared with participants with unmeasurable f‐Hb. After both screening rounds, the Dutch CRC screening program had a low incidence of interval CRC and an associated high FIT‐sensitivity. Our findings suggest there is a potential for further optimizing CRC screening programs with the use of risk‐stratified CRC screening based on prior f‐Hb.
- 1 August 2015
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 13 (8) , 1464-1471.e4
Gender Differences in Fecal Immunochemical Test Performance for Early Detection of Colorectal Neoplasia
- 1 August 2015
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 13 (8) , 1464-1471.e4
Gender Differences in Fecal Immunochemical Test Performance for Early Detection of Colorectal Neoplasia